GlassScriptPhysician profile
Jeffrey N Johnson
NPI 1689698318
$1,397.76
in general payments reported to CMS, 2019-2025
21 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $373 · 2021: $275 · 2022: $118 · 2023: $101 · 2024: $125 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $273.18 | 2020-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $188.44 | 2019-2021 | |
| Pfizer INC. | $154.43 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.73 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $101.87 | 2019-2025 | Eliquis |
| Novo Nordisk INC | $101.23 | 2019-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $91.60 | 2019-2022 | |
| Lilly USA, LLC | $84.59 | 2022-2025 | Mounjaro |
| Sunovion Pharmaceuticals INC. | $37.51 | 2019 | |
| Amgen INC. | $31.77 | 2020-2025 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $30.64 | 2019 | |
| Astellas Pharma US INC | $24.66 | 2021 | |
| Boston Scientific Corporation | $21.62 | 2025 | Watchman Access System |
| Xeris Pharmaceuticals, INC. | $18.63 | 2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $18.62 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $16.83 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.01 | 2023 | |
| Abbott Laboratories | $14.83 | 2021 | |
| Seqirus USA INC | $13.62 | 2024 | Flucelvax, Fluad |
| Allergan, INC. | $12.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.